News

Trabectedin (Yondelis) chemotherapy was approved by the FDA for treatment of patients with specific metastatic soft tissue sarcomas-liposarcoma and leiomyosarcoma-who previously received chemotherapy that included an anthracycline.

The FDA has approved MM-398, branded as Onivyde (irinotecan liposome injection) in combination with 5-fluorouracil (5-FU) chemotherapy and leucovorin for patients with metastatic pancreatic cancer. The treatment follows prior administration of a gemcitabine-based regimen.

Despite having significantly elevated risks of long-term health problems, many cancer survivors eat poorer-quality diets than the general population.

The American Cancer Society (ACS) has revised its breast cancer screening guidelines, recommending that women at an average risk of breast cancer receive a mammography annually starting at age 45-5 years later than previous recommendations formulated in 2003.

New evidence suggests that there may be a safe and effective treatment option for older patients with Hodgkin lymphoma who are ineligible for chemotherapy.

SonaCare Medical's Sonablate 450 ultrasound device has received de novo clearance by the FDA for ablation of prostate tissue.

Not always reported by men with prostate cancer.

Debilitating neuropathy led to Mark's diagnosis of WM, and he has been subjected to many rounds of plasmapheresis and a number of demanding treatments without great success.

The majority of survivors and patients with cancer want to work but are faced with common challenges such as fatigue, managing side effects, and taking longer to complete work tasks, a recent survey has found.

Last month, we got the chance to discuss DCIS with three doctors from NYU Cancer Center: Dr. Deborah Axelrod, Dr. Julia Smith, and Dr. David Kleinberg.

Choose less, weigh less

Regardless of breast cancer subtype or stage, minority women are more likely to be diagnosed with more advanced-stage breast cancer and receive inappropriate treatment, a new study has found.

Study finds some individuals have genetic variants that allow them to have long-term exposure to a carcinogen without developing lung cancer.

The PD-1 agent nivolumab (Opdivo) was FDA approved October 9 for patients with non-squamous non-small cell lung cancer (NSCLC) whose cancer progressed during or following platinum-based chemotherapy.

The antiemetic NK-1 antagonist aprepitant (Emend) was shown to significantly reduce cough in patients with lung cancer, according to findings of the first antitussive trial in patients with lung cancer using objective quantification of cough.

A novel approach using an automated system of remote monitoring coaching system can help relieve particular stressors caused by adult children caring for their parents receiving hospice care at home.

Short videos can enhance-though not replace-patient and family treatment conversations with their healthcare providers, a recent study shows.

Ashley Dietrich was diagnosed with Hodgkin's Lymphoma while pregnant at 6 weeks. Ashley's son, Beckett Anthony, was born in 2011.

New Online Resources Now Available for Lung Cancer Caregivers

Genetic counseling before BRCA genetic testing improves patient knowledge, understanding, and satisfaction. However, a new analysis has found that most women undergoing BRCA genetic testing did not receive counseling prior to testing, despite national guidelines and recommendations.

New Technology Streamlines Financial Assistance Approval for Eligible Patients

Good nutrition is an important component in any patient's cancer journey. A healthy diet is needed to maintain appropriate body weight and strength, absorb the proper nutrients, keep body tissue healthy, and fight infection.

Optune (formally the NovoTTF-100A System) in combination with adjuvant temozolomide, has been approved by the FDA to treat patients newly diagnosed with glioblastoma multiforme (GBM) following surgery, chemotherapy, and radiation therapy.

Improvement or a necessary evil?

For patients with painful bone metastases, an intervention combining palliative care with radiation oncology led to better results, according to preliminary findings from a new study.

The American Society of Clinical Oncology (ASCO) and the American Academy of Hospice and Palliative Medicine (AAHPM) have partnered to create a consensus definition of high-quality palliative care incorporated into oncology practices.

An important aspect of patient-centered care is ensuring that those with advanced cancers have their values respected and their goals for care met at the end of life.

Women with a certain type of breast cancer whose tumors have a favorable gene-expression profile may be able to safely avoid chemotherapy without an increased risk of recurrence, a new study has found.

The PD-1 inhibitor pembrolizumab (Keytruda) was approved by the FDA today for patients with pretreated advanced non–small cell lung cancer (NSCLC) across all histologies whose tumors express PD-L1.

Little is known about the potential benefits of adjuvant radiotherapy in older women diagnosed with triple-negative breast cancer (TNBC), but findings of a retrospective study reported at the 2015 Breast Cancer Symposium suggest that the approach may be worth considering for this population.